SCHEMBL22741550

SCHEMBL22741550

Cc1ccc(N(c2ccc(C)cc2)c2ccc3cc4c(cc3c2)oc2c(-c3ccccc3)c3oc5cc6cc(N(c7ccc(C)cc7)c7ccc(C)cc7)ccc6cc5c3c(-c3ccccc3)c24)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERAP1 Q9NZ08 1/20 0.33
▸ MAOB P27338 1/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32
▸ KMT2A Q03164 4/20 0.31
▸ MEN1 O00255 3/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ THRB P10828 1/20 0.31
▸ RECQL P46063 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ KDM4E B2RXH2 4/20 0.31
▸ SMN1; SMN2 Q16637 3/20 0.31
▸ HPGD P15428 2/20 0.31
▸ NPC1 O15118 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22741145 0.94 ERAP1 (0.33) ERAP1MAOBALDH1A1CYP1A2CYP2C9
SCHEMBL22742305 0.93 ERAP1 (0.32) ERAP1MAOBALDH1A1CYP1A2CYP2C9
SCHEMBL22741557 0.93 ESR1 (0.33) ERAP1KMT2AMEN1TDP1THRB
SCHEMBL22742917 0.92 ERAP1 (0.32) ERAP1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL22742935 0.89 MEN1 (0.33) ERAP1MAOBALDH1A1CYP1A2CYP2C9
SCHEMBL22742127 0.89 KDM4E (0.34) ERAP1MAOBALDH1A1CYP1A2CYP2C9
SCHEMBL22742910 0.89 ERAP1 (0.34) ERAP1ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL22742194 0.88 KDM4E (0.33) ERAP1MAOBALDH1A1CYP1A2CYP2C9
SCHEMBL22741551 0.88 ESR1 (0.32) POLBESR1
SCHEMBL22740595 0.87 ESR1 (0.33) ERAP1ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, TMEM109, LEF1 ERAP1 4543/4885MAOB 529/4885ALDH1A1 216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback